On 1 May 2018, Henrik Oevermann will become the new CEO of DIOSNA Dierks & Söhne, a German manufacturer of machines to the pharmaceutical industry. He succeeds to Dr Wolfgang Eißer who will have his official retirement at the end of April 2018.
After 20 years in charge of the company, Dr Eißer is leaving as an experienced industry expert who has led the company very successfully with great engagement and high identification. Dr Eißer has made a significant contribution to the on-going increase in turnover, the development into an international leading company and the expansion of the business units. He will have an advisory function on the supervisory board of the French holding company LINXIS for another two years.
Henrik Oevermann becomes the new CEO. He has been working for DIOSNA since 2011, currently as the CFO and Head of Bakery Division. "I am very pleased that we can fill the managing directorship from among our own ranks“, says Dr Eißer. "That is how we ensure the continuity of our successful business policy and our resolute market orientation in the long term.“